Beryl Drugs Q1 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
21.07
0.03 (0.14%)
0.03 (0.14%)Volume680.00
Updated: Fri 6 Feb, 2026 | 15:03:58
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4.67 | 5.04 | -7.41% | 5.58 | -16.45% |
| Depreciation/ Amortization | 0.38 | 0.32 | 20.32% | 0.28 | 35.18% |
| Operating Income | 0.13 | -1.07 | 0.00% | 0.67 | -80.59% |
| Net Income | 0.02 | 0.15 | -86.11% | 0.37 | -94.26% |
| Other Operating Expenses Total | 1.73 | 1.31 | 31.63% | 1.35 | 27.48% |
| Net Income Before Taxes | 0.07 | 0.10 | -31.53% | 0.50 | -85.94% |
| Total Revenue | 4.79 | 3.97 | 20.65% | 6.25 | -23.28% |
| Selling/ General/ Admin Expenses Total | 0.53 | 0.59 | -10.18% | 0.50 | 7.55% |
| Diluted Normalized EPS | 0.04 | 0.30 | -86.73% | 0.73 | -94.52% |